8-K - Anebulo Pharmaceuticals Inc. | Modeledge

Anebulo Pharmaceuticals Inc.

Filing type: 8-K
Filing date: Feb 5, 2026
Updated: Feb 6, 2026 · 7:20 AM

Filing

8-KNotice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events

Exhibits

EX-99.1Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events GRAPHICGraphic